MELATONIN AS A CHRONOBIOTIC/ANTICANCER AGENT: CELLULAR, BIOCHEMICAL, AND MOLECULAR MECHANISMS OF ACTION AND THEIR IMPLICATIONS FOR CIRCADIAN-BASED CANCER THERAPY

BLASK, D.E., SAUER, L.A., & DAUCHY, R.T.. (2002). MELATONIN AS A CHRONOBIOTIC/ANTICANCER AGENT: CELLULAR, BIOCHEMICAL, AND MOLECULAR MECHANISMS OF ACTION AND THEIR IMPLICATIONS FOR CIRCADIAN-BASED CANCER THERAPY. CURRENT TOPICS MEDICINAL CHEMISTRY, 2(2), 113-132. SID. https://sid.ir/paper/660330/en

BLASK D.E., SAUER L.A., DAUCHY R.T.. MELATONIN AS A CHRONOBIOTIC/ANTICANCER AGENT: CELLULAR, BIOCHEMICAL, AND MOLECULAR MECHANISMS OF ACTION AND THEIR IMPLICATIONS FOR CIRCADIAN-BASED CANCER THERAPY. CURRENT TOPICS MEDICINAL CHEMISTRY[Internet]. 2002;2(2):113-132. Available from: https://sid.ir/paper/660330/en

D.E. BLASK, L.A. SAUER, and R.T. DAUCHY, “MELATONIN AS A CHRONOBIOTIC/ANTICANCER AGENT: CELLULAR, BIOCHEMICAL, AND MOLECULAR MECHANISMS OF ACTION AND THEIR IMPLICATIONS FOR CIRCADIAN-BASED CANCER THERAPY,” CURRENT TOPICS MEDICINAL CHEMISTRY, vol. 2, no. 2, pp. 113–132, 2002, [Online]. Available: https://sid.ir/paper/660330/en